Remove Blogging Remove Patents Remove San Diego Remove Startup
article thumbnail

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.

article thumbnail

Exit Interview: Lita Nelsen on MIT Tech Transfer, Startups & Culture

Xconomy

Lita Nelsen has seen it up close—and played a part in its evolution—from her studies there in the 1960s, to her business-school fellowship in the late 1970s, to her 30 years working in MIT’s Technology Licensing Office. And so that’s what Stanford did, so it was set up in that model. Then it got acquired by Millipore.

Startup 67
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More

Xconomy

The patent holder, the University of Toronto, gave companies the right to manufacture insulin. But the university also allowed them to patent the improvements they made, which enabled them to slap higher prices on each new version. In the nearly 100 years since insulin’s discovery, no generic version has become available in the U.S.

Patents 77
article thumbnail

After Decades of R&D, Bose Amps Up VC Deals in AR, Wearables, Wellness

Xconomy

Bose’s Steve Romine says that’s still an important focus for the Framingham, MA-based company, which has been awarded hundreds of patents for advances in technologies such as noise-canceling headphones. But in the past few years, Bose has also started to look outside its walls for other sources of innovation.

article thumbnail

Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More

Xconomy

The long running patent feud over CRISPR-Cs9 gene editing appears to be over, just as U.S. biotech companies gear up for the first human tests of the landmark technology. This week, a federal appeals court upheld a previous ruling handing a CRISPR-Cas9 patent to the Broad Institute of MIT and Harvard.

Patents 52
article thumbnail

Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes

Xconomy

It was fitting this week that, in the lead-up to two of biomedicine’s biggest self-celebrations, we were served ample reminder of the industry’s expensive decisions gone wrong. Thousands of others will head to San Francisco for BIO, which has a distinct international flavor. But the U.S.

article thumbnail

Talking Driverless Cars, March Madness on Stocks and Jocks Radio

Xconomy

I hit the airwaves Friday morning to talk venture capital, startups, self-driving cars, and March Madness. Stocks and Jocks , a Chicago-based weekday business and sports talk radio program, invited me on the show to share my thoughts on some of the latest trends in the startup world. I also made some biased predictions about.

Patents 52